ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982

Kennedy To Propose NIH Construction Authority, Legislation Using IOM Study Recommendations

January 13, 1989

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

Drug Development Effort Criticized

April 18, 1975